ALKS vs HCA · P/E 14, rev $1.56B vs P/E 17, rev $75.60B
Alkermes Plc (ALKS) versus HCA Holdings Inc (HCA) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
HCA Holdings Inc (HCA) is a medical care facilities company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported HCA revenue for 2025-12-31 was $75.60B. Net income was $6.78B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
Not investment advice. Open the ALKS and HCA stock pages for the full models.
Not investment advice.